Arjuna et al., 2024 - Google Patents
Development of samarium-doped phosphate glass microspheres for internal radiotheranostic applicationsArjuna et al., 2024
- Document ID
- 13395761422717202420
- Author
- Arjuna A
- Milborne B
- Putra A
- Mulyaningsih T
- Setiawan H
- Islam M
- Felfel R
- Ahmed I
- Publication year
- Publication venue
- International Journal of Pharmaceutics
External Links
Snippet
Internal radiotherapy delivers radioactive sources inside the body, near to or into malignant tumours, which may be particularly effective when malignancies are not responding to external beam radiotherapy. A pure beta emitter, 90 Y, is currently used for internal …
- 239000004005 microsphere 0 title abstract description 159
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1798580B (en) | Microspheres comprising therapeutic and diagnostic radioactive isotopes | |
| CN1946432B (en) | Particulate materials and compositions for radiation therapy | |
| Zweit | Radionuclides and carrier molecules for therapy | |
| Arjuna et al. | Development of samarium-doped phosphate glass microspheres for internal radiotheranostic applications | |
| Howell et al. | Relative biological effectiveness of alpha-particle emitters in vivo at low doses | |
| Howell et al. | Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells | |
| Häfeli et al. | Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation | |
| EP3223867B1 (en) | Radioembolic particles | |
| Bakht et al. | Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy | |
| Dellepiane et al. | 47Sc and 46Sc cross-section measurement for an optimized 47Sc production with an 18 MeV medical PET cyclotron | |
| Sun et al. | Sub‐Micrometer Au@ PDA‐125I Particles as Theranostic Embolism Beads for Radiosensitization and SPECT/CT Monitoring | |
| Li et al. | Diagnostic performance of theranostic radionuclides used in transarterial radioembolization for liver cancer | |
| Ghosh et al. | Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb] Yb2O3 nanoseeds | |
| Zhou et al. | Radioactive microspheres for selective internal radiation therapy of hepatocellular carcinoma | |
| Vimalnath et al. | Practicality of production of 32P by direct neutron activation for its utilization in bone pain palliation as Na3 [32P] PO4 | |
| Adelstein | Merrill C. Sosman Lecture. The Auger process: a therapeutic promise? | |
| Chakraborty et al. | 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints | |
| Wang | Progress in californium-252 neutron brachytherapy | |
| Li et al. | Preparation of 125I brachytherapy seeds by iodinating carbon bars with a silver coating | |
| Renaldin et al. | Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide | |
| Wang et al. | Design and in vitro evaluation of 223Ra/99mTc-loaded spherical nano-hydroxyapatite in bone tumor therapy | |
| Alcocer‐Ávila et al. | Physics and small‐scale dosimetry of α α‐emitters for targeted radionuclide therapy: The case of 211 At ^211\rmAt | |
| Putra et al. | Preliminary study of a transarterial radioembolization agent using Samarium-153 microspheres: synthesis, characterization, and in vivo evaluation in normal mice | |
| Fisher | Alpha particle emitters in medicine | |
| Plotnikova et al. | Radiopaque Glass Ceramic with Calcium Tantalate Microcrystals for the Treatment of Malignant Neoplasms |